Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity? - Wikidata - awgldk - TriplyDB

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

http://www.wikidata.org/entity/Q41166380

about

The Spectrum of Differences between Childhood and Adulthood Celiac Disease Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.

P2860

Q26778458-27797B7F-4F15-4E01-ACB0-ED0A0556AA59 Q45834829-E839374C-CB66-4D58-920A-6B9557BD0F06

P2860

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

http://www.wikidata.org/entity/Q41166380

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

@en

type

label

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

@en

prefLabel

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

@en

P1433

Q41166380-EC63BA08-E850-4B3E-BCDD-34F68BCB7EC3

P1476

Q41166380-7628CBAE-9133-471C-9CFC-DCE7A8263280

P2093

Q41166380-0E9B972D-E9FF-4E2E-A36F-AB3F1F18F583

Q41166380-A2EDE5A6-4234-48B2-B066-660C61D41600

Q41166380-A3FC9992-E5FD-4A4E-A542-0D31B3C6E8E1

Q41166380-CA7888FD-8CCA-4367-A4AF-4C6CB7D43FE6

P2860

Q41166380-05E2CD5E-3483-4272-9CEB-B16592BCFD3A

Q41166380-0BAE8637-3257-4826-99FA-04A076AAC162

Q41166380-11A572E8-9BEE-4F6E-A880-FF1034CC2AB2

Q41166380-143160FA-7120-4006-A114-D063E77FE922

Q41166380-4EFB6553-4E95-431B-BB7F-9539FB0B20F6

Q41166380-55CBC49D-EF57-4B81-86C6-12A3DAE7071C

Q41166380-55E311C4-3E9C-4B26-95CC-3ECEB7C4D73A

Q41166380-634FC7AB-885F-46BA-BDF8-000102895B31

Q41166380-684E1EEA-0E6F-4824-B0C9-36DCF42ED7A8

Q41166380-8836CCF7-C8F5-4A25-8DE2-048370818B2E

P304

Q41166380-539A669A-88A9-4C3D-81F3-F37C044966C8

P31

Q41166380-4428A880-BB30-4893-82A4-E9D360944127

P356

Q41166380-866749AF-8F2D-456F-ADD9-D02A8E461DC5

P433

Q41166380-6A9BB073-7B70-4BED-9E86-4254C7214AD5

P478

Q41166380-C7C47056-3FE8-4CBA-90A1-CAE92638FDF4

P577

Q41166380-8F2B509A-13B2-4FA8-86D9-0BFB59ADC7DB

P698

Q41166380-21D1AD07-4AB7-4D17-9B36-071BAC4019E1

P356

107327481502200218

P1433

P1476

Primary Enteropathy-Associated T-Cell Lymphoma Type 2: An Emerging Entity?

@en

P2093

Doris H Toro

http://www.w3.org/2001/XMLSchema#string

Nicole M Grigg-Gutierrez

http://www.w3.org/2001/XMLSchema#string

Rodolfo Estremera-Marcial

http://www.w3.org/2001/XMLSchema#string

William W Caceres

http://www.w3.org/2001/XMLSchema#string

P2860

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

Primary colorectal lymphoma: An overview.

Primary colorectal lymphomas.

Enteropathy-type T-cell lymphoma.

Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Intestinal T-cell lymphomas: a retrospective analysis of 68 cases in China.

Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.

How I treat enteropathy-associated T-cell lymphoma.

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.

P304

242-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481502200218

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26068772

http://www.w3.org/2001/XMLSchema#string